MedPath
HSA Approval

TRIMBOW PRESSURISED INHALATION SOLUTION 200/6/12.5 μg PER ACTUATION

SIN17226P

TRIMBOW PRESSURISED INHALATION SOLUTION 200/6/12.5 μg PER ACTUATION

TRIMBOW PRESSURISED INHALATION SOLUTION 200/6/12.5 μg PER ACTUATION

April 30, 2025

ORIENT EUROPHARMA PTE LTD

Regulatory Information

ORIENT EUROPHARMA PTE LTD

Therapeutic

Prescription Only

Formulation Information

AEROSOL, METERED

RESPIRATORY (INHALATION)

Medical Information

R03AL09

Manufacturer Information

ORIENT EUROPHARMA PTE LTD

Chiesi Farmaceutici SpA

Active Ingredients

Beclometasone dipropionate

0.20000mg/actuation

Beclomethasone Dipropionate

Formoterol fumarate dihydrate

0.00600mg/actuation

Aluminum sulfate

Glycopyrronium bromide

0.01250mg/actuation

Glycopyrronium

Documents

Package Inserts

Trimbow pMDI 200_6_12.5 mcg.pdf

Approved: April 30, 2025

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TRIMBOW PRESSURISED INHALATION SOLUTION 200/6/12.5 μg PER ACTUATION - HSA Approval | MedPath